Constitutional activation of Jak-Stat pathway, secondary to activating mutations in JAK2, CALR or MPL genes, is a prominent feature of MPN, including PMF [13], but these mutations are infrequent in MDS [14–18]. This evidence concerns the gene JAK2 and myelodysplastic syndrome.